Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Daisuke Watanabe is active.

Publication


Featured researches published by Daisuke Watanabe.


Gut | 2018

A comparison of the resection rate for cold and hot snare polypectomy for 4–9 mm colorectal polyps: a multicentre randomised controlled trial (CRESCENT study)

Takuji Kawamura; Yoji Takeuchi; Satoshi Asai; Isao Yokota; Eisuke Akamine; Minoru Kato; Takuji Akamatsu; Kazuhiro Tada; Yoriaki Komeda; Mineo Iwatate; Ken Kawakami; Michiko Nishikawa; Daisuke Watanabe; Atsushi Yamauchi; Norimasa Fukata; Masaaki Shimatani; Makoto Ooi; Koichi Fujita; Yasushi Sano; Hiroshi Kashida; Satoru Hirose; Hiroyoshi Iwagami; Noriya Uedo; Satoshi Teramukai; Kiyohito Tanaka

Objective To investigate the success rate of cold snare polypectomy (CSP) for complete resection of 4–9 mm colorectal adenomatous polyps compared with that of hot snare polypectomy (HSP). Design A prospective, multicentre, randomised controlled, parallel, non-inferiority trial conducted in 12 Japanese endoscopy units. Endoscopically diagnosed sessile adenomatous polyps, 4–9 mm in size, were randomly assigned to the CSP or HSP group. After complete removal of the polyp using the allocated technique, biopsy specimens from the resection margin after polypectomy were obtained. The primary endpoint was the complete resection rate, defined as no evidence of adenomatous tissue in the biopsied specimens, among all pathologically confirmed adenomatous polyps. Results A total of 796 eligible polyps were detected in 538 of 912 patients screened for eligibility between September 2015 and August 2016. The complete resection rate for CSP was 98.2% compared with 97.4% for HSP. The non-inferiority of CSP for complete resection compared with HSP was confirmed by the +0.8% (90% CI −1.0 to 2.7) complete resection rate (non-inferiority p<0.0001). Postoperative bleeding requiring endoscopic haemostasis occurred only in the HSP group (0.5%, 2 of 402 polyps). Conclusions The complete resection rate for CSP is not inferior to that for HSP. CSP can be one of the standard techniques for 4–9 mm colorectal polyps. (Study registration: UMIN000018328)


Endoscopy | 2016

Feasibility and safety of endoscopic submucosal dissection for lesions involving the ileocecal valve

Tetsuya Yoshizaki; Takashi Toyonaga; Shinwa Tanaka; Yoshiko Ohara; Fumiaki Kawara; Shinichi Baba; Eiji Tsubouchi; Hiroshi Takihara; Daisuke Watanabe; Tsukasa Ishida; Namiko Hoshi; Yoshinori Morita; Eiji Umegaki; Takeshi Azuma

BACKGROUND AND STUDY AIM Endoscopic submucosal dissection (ESD) has been applied to treat early colorectal cancers. The aim of this study was to clarify the clinical course of ESD for lesions involving the ileocecal valve (ICV) by evaluating the successful resection rates, and the risk and frequency of adverse events. PATIENTS AND METHODS The outcome of ESD on 38 ICV lesions was compared with the outcome of 132 cecal lesions that did not involve the ICV or appendiceal orifice during the same study period. The factors related to longer procedure time, postoperative stricture development, and tumor recurrence were investigated for ESD of ICV lesions. RESULTS There was no significant difference between the ICV and non-ICV groups in the en block resection rates. The median procedure time was significantly longer in the ICV group than in the non-ICV group, with a point estimate of the difference of 37 minutes (95 % confidence interval [CI] 20.00 to 56.00; P  < 0.01). None of the patients developed symptomatic post-ESD stricture or tumor recurrence. ESD procedure duration was ≥ 120 minutes in 16 lesions and < 120 minutes in 22 lesions of the ICV group. A specimen diameter of ≥ 40 mm and tumor extension into terminal ileum were factors related to a longer procedure time (odds ratio [OR] 8.40, 95 %CI 1.53 to 46.10, P = 0.01; OR 10.60, 95 %CI 2.17 to 51.40, P  < 0.01, respectively). CONCLUSIONS ICV lesions can be resected by ESD without major adverse events or causing symptomatic stricture development. However, ESD for ICV lesions should be performed only by expert endoscopists, as the procedure requires accomplished endoscopic skill and experience.


Clinical Journal of Gastroenterology | 2015

Electrolyte depletion syndrome (McKittrick–Wheelock syndrome) successfully treated by endoscopic submucosal dissection

Yoshiko Ohara; Takashi Toyonaga; Daisuke Watanabe; Namiko Hoshi; Soichiro Adachi; Tetsuya Yoshizaki; Fumiaki Kawara; Shinwa Tanaka; Tsukasa Ishida; Tatsuya Okuno; Nobunao Ikehara; Yoshinori Morita; Eiji Umegaki; Hiroshi Yokozaki; Takeshi Azuma

A 66-year-old woman presented to us with malaise, anorexia and rectal mucous discharge, and her laboratory data showed severe hyponatremia, hypokalemia, hypochloremia and renal failure. Computed tomography revealed massive occupation of the rectum by a large tumor. Colonoscopy revealed a mucus-rich villous tumor in the rectum. As there were no other factors that could cause an electrolyte disorder, she was diagnosed with McKittrick–Wheelock syndrome (MWS). The current standard treatment for MWS is partial surgical colectomy. However, surgeries are invasive and postoperative complications sometimes become an issue. After confirming no signs of submucosal invasion of the tumor by magnifying chromoendoscopic examination, endoscopic submucosal dissection (ESD) was indicated. The tumor was completely removed en bloc without adverse events. The histology showed a mucosal adenocarcinoma containing a villous component, 24.5 x 17.0 cm in size. This removal dramatically improved the patient’s symptoms and the electrolyte abnormalities without medication. Although several sessions of endoscopic balloon dilation were required to treat postoperative stricture, she has been symptom-free and had no recurrence for 4 years after treatment. We experienced a case of MWS treated by ESD instead of surgery. ESD should be feasible and beneficial for the treatment of MWS.


Digestive Diseases and Sciences | 2018

Proton Pump Inhibitors Increase the Susceptibility of Mice to Oral Infection with Enteropathogenic Bacteria

Eiichiro Yasutomi; Namiko Hoshi; Soichiro Adachi; Takafumi Otsuka; Lingling Kong; Yuna Ku; Haruka Yamairi; Jun Inoue; Tsukasa Ishida; Daisuke Watanabe; Makoto Ooi; Masaru Yoshida; Tomoya Tsukimi; Shinji Fukuda; Takeshi Azuma

Background and AimsProton pump inhibitors (PPIs) are among the most frequently prescribed medications. Side effects including an increased risk of intestinal infections have been reported. It is assumed that PPIs can increase susceptibility to enteropathogens; however, the underlying mechanisms are unknown. Here in this study, we explored whether Lansoprazole (Laz), one of the PPIs, increases the susceptibility to enteropathogens, and further investigated the mechanism of it.MethodsMice were administered Laz intraperitoneally once daily and orally infected with Citrobacter rodentium (C. rodentium). The establishment of intestinal infection was assessed by histology and inflammatory cytokine expression levels measured by quantitative PCR. To test whether Laz changes the intestinal environment to influence the susceptibility, intestinal pH, microbiota, metabolites and immune cell distributions were evaluated via pH measurement, 16S rRNA gene sequencing, metabolome, and flow cytometry analyses after Laz administration.ResultsColitis was induced with less C. rodentium in Laz-treated mice as compared with the controls. We found that increased numbers of C. rodentium could reach the cecum following Laz administration. Laz increased pH in the stomach but not in the intestines. It induced dysbiosis and changed the metabolite content of the small intestine. However, these changes did not lead to alterations of immune cell distribution.ConclusionsLaz raised susceptibility to C. rodentium as increased numbers of the pathogen reach the site of infection. Our results suggest that it was due to increased stomach pH which allowed more peroral enteropathogens to pass the stomach, but not because of changes of intestinal environment.


Stem Cells Translational Medicine | 2018

The Generation of Human γδT Cell‐Derived Induced Pluripotent Stem Cells from Whole Peripheral Blood Mononuclear Cell Culture

Daisuke Watanabe; Michiyo Koyanagi-Aoi; Mariko Taniguchi‐Ikeda; Yukiko Yoshida; Takeshi Azuma; Takashi Aoi

γδT cells constitute a small proportion of lymphocytes in peripheral blood. Unlike αβT cells, the anti‐tumor activities are exerted through several different pathways in a MHC‐unrestricted manner. Thus, immunotherapy using γδT cells is considered to be effective for various types of cancer. Occasionally, however, ex vivo expanded cells are not as effective as expected due to cell exhaustion. To overcome the issue of T‐cell exhaustion, researchers have generated induced pluripotent stem cells (iPSCs) that harbor the same T‐cell receptor (TCR) genes as their original T‐cells, which provide nearly limitless sources for antigen‐specific cytotoxic T lymphocytes (CTLs). However, these technologies have focused on αβT cells and require a population of antigen‐specific CTLs, which are purified by cell sorting with HLA‐peptide multimer, as the origin of iPS cells. In the present study, we aimed to develop an efficient and convenient system for generating iPSCs that harbor rearrangements of the TCRG and TCRD gene regions (γδT‐iPSCs) without cell‐sorting. We stimulated human whole peripheral blood mononuclear cell (PBMC) culture using Interleukin‐2 and Zoledronate to activate γδT cells. Gene transfer into those cells with the Sendai virus vector resulted in γδT cell‐dominant expression of exogenous genes. The introduction of reprogramming factors into the stimulated PBMC culture allowed us to establish iPSC lines. Around 70% of the established lines carried rearrangements at the TCRG and TCRD gene locus. The γδT‐iPSCs could differentiate into hematopoietic progenitors. Our technology will pave the way for new avenues toward novel immunotherapy that can be applied for various types of cancer. Stem Cells Translational Medicine 2018;7:34–44


International Archives of Allergy and Immunology | 2017

Indigo Naturalis Ameliorates Oxazolone-Induced Dermatitis but Aggravates Colitis by Changing the Composition of Gut Microflora

Soichiro Adachi; Namiko Hoshi; Jun Inoue; Eiichiro Yasutomi; Takafumi Otsuka; Ramesh Dhakhwa; Zi Wang; Yuna Koo; Toshihiro Takamatsu; Haruka Yamairi; Daisuke Watanabe; Makoto Ooi; Toshihito Tanahashi; Shin Nishiumi; Masaru Yoshida; Takeshi Azuma

Background: Indigo naturalis (IND) is an herbal medicine that has been used as an anti-inflammatory agent to treat diseases including dermatitis and inflammatory bowel disease in China. However, the mechanism by which IND exerts its immunomodulatory effect is not well understood. Methods: A murine model of dermatitis and inflammatory bowel disease, both induced by oxazolone (OXA), was treated with IND. The severity of dermatitis was evaluated based on ear thickness measurements and histological scoring. The severity of colitis was evaluated by measuring body weight, histological scoring, and endoscopic scoring. The expression of inflammatory cytokines in ear and colon tissue was evaluated using real-time PCR. 16S rRNA DNA sequencing of feces from OXA-induced colitis mice was performed before and after IND treatment. The effects of IND on OXA-induced colitis were also evaluated after depleting the gut flora with antibiotics to test whether alteration of the gut flora by IND influenced the course of intestinal inflammation in this model. Results: IND treatment ameliorated OXA dermatitis with a reduction in IL-4 and eosinophil recruitment. However, OXA colitis was significantly aggravated in spite of a reduction in intestinal IL-13, a pivotal cytokine in the induction of the colitis. It was found that IND dramatically altered the gut flora and IND no longer exacerbated colitis when colitis was induced after gut flora depletion. Conclusions: Our data suggest that IND could modify the inflammatory immune response in multiple ways, either directly (i.e., modification of the allergic immune cell activity) or indirectly (i.e., alteration of commensal compositions).


Endoscopy | 2014

Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy

Daisuke Watanabe; Makoto Ooi; Namiko Hoshi; Michitaka Kohashi; Tomoo Yoshie; Nobunao Ikehara; Masaru Yoshida; Emmy Yanagita; Takashi Yamasaki; Tomoo Itoh; Takeshi Azuma


Surgical Endoscopy and Other Interventional Techniques | 2018

Clinical outcomes of deep invasive submucosal colorectal cancer after ESD

Daisuke Watanabe; Takashi Toyonaga; Makoto Ooi; Tetsuya Yoshizaki; Yoshiko Ohara; Shinwa Tanaka; Fumiaki Kawara; Tsukasa Ishida; Yoshinori Morita; Eiji Umegaki; Takeru Matsuda; Yasuo Sumi; Mari Nishio; Hiroshi Yokozaki; Takeshi Azuma


Gastrointestinal Endoscopy | 2018

839 SIGNIFICANT REDUCTION OF POST-OPERATIVE GASTROESOPHAGEAL REFLUX DEVELOPMENT BY THE POSTERIOR MYOTOMY USING TWO PENETRATING VESSELS (TPVS) IN PERORAL ENDOSCOPIC MYOTOMY (POEM)

Shinwa Tanaka; Fumiaki Kawara; Hirofumi Abe; Ryusuke Ariyoshi; Daisuke Watanabe; Namiko Hoshi; Takashi Toyonaga


Diseases of The Esophagus | 2018

Muscle layer thickness affects the peroral endoscopic myotomy procedure complexity

Daisuke Watanabe; Shinwa Tanaka; Ryusuke Ariyoshi; Hirohumi Abe; Fumiaki Kawara; Takashi Toyonaga

Collaboration


Dive into the Daisuke Watanabe's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge